Following the 2001 bioterrorism attacks with anthrax, the U.S. government focused on becoming better prepared for chemical, biological, radiological, and nuclear threats. Part of that process was the use of modeling and simulation to support public health planning and decision making. Responding to the 2009 H1N1 influenza pandemic was challenging due to the lack of rapid detection assays, case reporting, and hospitalization data. We dodged a bullet as the clinical severity of the H1N1 pandemic was relatively low. The COVID-19 pandemic was drastically different, but the availability of rapid diagnostic tests and the unprecedented availability of case data down to the county level allowed modelers to explore the characteristics of the virus and to predict the future cases, hospitalizations, and deaths. We review how modeling and simulation has changed with respect to supporting public health since the anthrax attacks to identify lessons learned as we try to improve our methods and approaches for future public health emergencies.
No takes yet. Share an insight, caveat, or question.
Prasith Baccam (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: